A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
Suping Li(National Center for Nanoscience and Technology), Qiao Jiang(National Center for Nanoscience and Technology), Shaoli Liu(National Center for Nanoscience and Technology), Yinlong Zhang(Jilin University), Yanhua Tian(Peking University), Chen Song(National Center for Nanoscience and Technology), Jing Wang(National Center for Nanoscience and Technology), Yiguo Zou(National Center for Nanoscience and Technology), Gregory J. Anderson(QIMR Berghofer Medical Research Institute), Jing-Yan Han(Peking University), Yung Chang(Arizona State University), Yan Liu(Arizona State University), Chen Zhang(Chinese Academy of Sciences), Liang Chen(Jinan University), Guang‐Biao Zhou(Chinese Academy of Sciences), Guangjun Nie(National Center for Nanoscience and Technology), Hao Yan(Arizona State University), Baoquan Ding(National Center for Nanoscience and Technology), Yuliang Zhao(National Center for Nanoscience and Technology)
Cited by 1,476
Abstract
Related Papers
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Rakesh K. Jain|Science|2005|5.4k